e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Non-exhaled biomarkers in the assessment of airways disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A cross-sectional study on association between stable COPD & metabolic syndrome (Syndrome X)
Angshuman Mukherjee (Kolkata, India), Angshuman Mukherjee, Samim Khan, Sumitra Basuthakur, Raja Dhar
Source:
International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Session:
Non-exhaled biomarkers in the assessment of airways disease
Session type:
Thematic Poster Session
Number:
3978
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Angshuman Mukherjee (Kolkata, India), Angshuman Mukherjee, Samim Khan, Sumitra Basuthakur, Raja Dhar. A cross-sectional study on association between stable COPD & metabolic syndrome (Syndrome X). Eur Respir J 2015; 46: Suppl. 59, 3978
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016
Lung function (LF) decline and hospitalization in subjects with the asthma-COPD overlap syndrome
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Prevalence of metabolic syndrome (MS) in a population of apneic patients:
A prospective study with cardiovascular risk estimation
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014
Asthma-COPD overlap syndrome (ACOS) versus ²pure² COPD: A distinct phenotype?
Source: International Congress 2016 – Best abstracts in asthma and COPD
Year: 2016
Differences between asthma-COPD overlap syndrome (ACOS) and adult-onset asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Metabolic syndrome in patients with COPD and their association with systemic inflammation
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Pharmacogenetic and clinicopathological markers of BA-COPD (overlap syndrome)
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014
15-years mortality in asthma-COPD overlap syndrome (ACOS) elderly population
Source: International Congress 2015 – Respiratory health across the life course
Year: 2015
COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Associations between severity of airflow obstruction and atherosclerosis: A cross-sectional study in Japan
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Metabolic syndrome in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014
Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Phenotypic and molecular-genetic features of asthma-COPD overlap syndrome (ACOS)
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Comorbidities and burden of COPD: A population based case-control study
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Risk scores for predicting death in COPD patients
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
Comorbidities, gender-differences and COPD severity: The French Palomb cohort
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Risk of CAP in COPD stratified by smoking status: A population-based cohort study in the UK
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016
The characteristics of ACOS in a population based asthma cohort
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept